Remove tag health-canada
article thumbnail

Risk-sharing agreements are growing at a rate of 24%

Pharmaceutical Technology

This is not the first treatment to come with a high price tag. Their widespread agreements are established in the UK, followed by seven additional countries (Australia, France, Netherlands, Spain, Poland, Italy, and Canada). million, according to GlobalData’s Price Intelligence (POLI), making it the most expensive drug in the world.

Marketing 105
article thumbnail

Risk sharing agreements soar as market access risk increases

Pharmaceutical Technology

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) defines risk sharing agreements as “an arrangement between a manufacturer and payer/provider that enables access to (coverage/reimbursement of) a health technology subject to specified conditions”. Click here to watch this webinar and access the presentation.

Marketing 102
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

The Health Survey for England 2019 reported that 28% of adults in the UK were obese and 36.2% A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% The UK and US are both undergoing an obesity crisis.

Medical 105
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

The Health Survey for England 2019 reported that 28% of adults in the UK were obese and 36.2% A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% The UK and US are both undergoing an obesity crisis.

Medical 98